144 related articles for article (PubMed ID: 8104325)
1. Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
Zadina JE; Kastin AJ; Kenigs V; Bruno C; Hackler L
Neurosci Lett; 1993 Jun; 155(2):220-2. PubMed ID: 8104325
[TBL] [Abstract][Full Text] [Related]
2. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
Gergen KA; Zadina JE; Kastin AJ; Paul D
Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
[TBL] [Abstract][Full Text] [Related]
4. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
Gergen KA; Zadina JE; Paul D
Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
[TBL] [Abstract][Full Text] [Related]
5. Cyclic analogues of Tyr-W-MIF-1 with prolonged analgesic activity and potency comparable to DAMGO and morphine.
Zadina JE; Kastin AJ; Hackler L; Chang SL
Peptides; 1994; 15(8):1567-9. PubMed ID: 7700858
[TBL] [Abstract][Full Text] [Related]
6. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
7. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
Zadina JE; Kastin AJ; Ge LJ; Hackler L
Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
[TBL] [Abstract][Full Text] [Related]
8. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
Erchegyi J; Kastin AJ; Zadina JE
Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
[TBL] [Abstract][Full Text] [Related]
9. Expression of the FOS proto-oncogene protein in brain after ICV administration of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
Gergen KA; Chang SL; Niu YF; Kastin AJ; Zadina JE
Peptides; 1994; 15(8):1505-11. PubMed ID: 7700853
[TBL] [Abstract][Full Text] [Related]
10. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
Zadina JE; Kastin AJ; Kersh D; Wyatt A
Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
[TBL] [Abstract][Full Text] [Related]
11. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.
Zadina JE; Paul D; Gergen KA; Ge LJ; Hackler L; Kastin AJ
Neurosci Lett; 1996 Aug; 215(1):65-9. PubMed ID: 8880755
[TBL] [Abstract][Full Text] [Related]
12. Cimetidine does not change the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
Krowicki ZK
Life Sci; 1991; 49(16):1163-8. PubMed ID: 1680211
[TBL] [Abstract][Full Text] [Related]
13. Involvement of spinal mu1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception.
Mizoguchi H; Nakayama D; Watanabe H; Ito K; Sakurada W; Sawai T; Fujimura T; Sato T; Sakurada T; Sakurada S
Eur J Pharmacol; 2006 Jul; 540(1-3):67-72. PubMed ID: 16730704
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
[TBL] [Abstract][Full Text] [Related]
15. Tyr-W-MIF-1-induced conditioned place preference.
Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
[TBL] [Abstract][Full Text] [Related]
16. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
Galina ZH; Kastin AJ
Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
[TBL] [Abstract][Full Text] [Related]
17. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
Hagan MM; Moss DE
Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
[TBL] [Abstract][Full Text] [Related]
19. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
Banks WA; Kastin AJ; Ehrensing CA
J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
Krowicki ZK
Neuropeptides; 1991 Aug; 19(4):281-5. PubMed ID: 1681456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
